Interim FDG-PET does not predict outcome in advanced-stage Hodgkin lymphoma patients treated with BEACOPP

被引:3
|
作者
Adams, Hugo J. A. [1 ]
Kwee, Thomas C. [2 ]
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Radiol & Nucl Med, Amsterdam, Netherlands
[2] Univ Groningen, Univ Med Ctr Groningen, Dept Radiol Nucl Med & Mol Imaging, Groningen, Netherlands
关键词
FDG-PET; Hodgkin lymphoma; POSITRON-EMISSION-TOMOGRAPHY;
D O I
10.1111/bjh.15602
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:758 / 760
页数:3
相关论文
共 50 条
  • [41] Gene expression-based outcome prediction in advanced stage classical Hodgkin lymphoma treated with BEACOPP
    Jachimowicz, Ron D.
    Klapper, Wolfram
    Glehr, Gunther
    Mueller, Horst
    Haverkamp, Heinz
    Thorns, Christoph
    Hansmann, Martin Leo
    Moeller, Peter
    Stein, Harald
    Rehberg, Thorsten
    von Tresckow, Bastian
    Reinhardt, H. C.
    Borchmann, Peter
    Chan, Fong Chun
    Spang, Rainer
    Scott, David W.
    Engert, Andreas
    Steidl, Christian
    Altenbuchinger, Michael
    Rosenwald, Andreas
    LEUKEMIA, 2021, 35 (12) : 3589 - 3593
  • [42] FDG-PET in the Staging of Patients with Hodgkin's Lymphoma
    Castagnoli, A.
    Versari, A.
    Rigacci, L.
    Gallamini, A.
    Matteini, M.
    Gregianin, M.
    Bianchi, A.
    Peano, S.
    Merli, F.
    Vaggelli, L.
    Levis, A.
    Chisesi, T.
    Pelosi, E.
    Biggi, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S145 - S145
  • [43] Concordance in interim PET reporting in the prospective HD 0607 clinical trial in advanced-stage Hodgkin lymphoma
    Biggi, Alberto
    Chauvie, Stephane
    Fallanca, Federico
    Chiaravalloti, Agostino
    Gregianin, Michele
    Ficola, Umberto
    Gallamini, Andrea
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [44] PROGNOSTIC VALUE OF PRE-RADIOTHERAPY FDG-PET IN ADVANCED HODGKIN' S DISEASE TREATED BY BEACOPP CHEMOTHERAPY REGIMEN
    Chiesa, S.
    De Santis, M. C.
    Teofili, L.
    Manfrida, S.
    Vannata, B.
    Frascino, V.
    Fiorentino, A.
    Calcagni, L.
    Hohaus, S.
    Balducci, M.
    RADIOTHERAPY AND ONCOLOGY, 2010, 94 : S44 - S45
  • [45] Interim FDG-PET/CT for therapy monitoring and prognostication in Hodgkin's Lymphoma
    Al-Ibraheem, Akram
    Anwer, Farah
    Juweid, Malik E.
    Shagera, Qaid Ahmed
    Khalaf, Aysar N.
    Obeidat, Shahed
    Mansour, Areen
    Ma'koseh, Mohammad
    Halahleh, Khalid
    Jaradat, Imad
    Almasri, Nidal
    Mansour, Asem
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [46] Interim FDG-PET/CT for therapy monitoring and prognostication in Hodgkin’s Lymphoma
    Akram Al-Ibraheem
    Farah Anwer
    Malik E. Juweid
    Qaid Ahmed Shagera
    Aysar N. Khalaf
    Shahed Obeidat
    Areen Mansour
    Mohammad Ma’koseh
    Khalid Halahleh
    Imad Jaradat
    Nidal Almasri
    Asem Mansour
    Scientific Reports, 12
  • [47] FDG-PET in aggressive non Hodgkin lymphoma: the prognostic value of interim evaluation
    Aloj, L.
    Frigeri, F.
    Caraco, C.
    Crisci, S.
    Farese, R.
    Ibello, F.
    Morisco, A.
    Capobianco, G.
    Volzone, F.
    Pinto, A.
    Lastoria, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S692 - S692
  • [48] Interim FDG-PET/CT in Hodgkin lymphoma: what are we actually looking at?
    Adams, Hugo J. A.
    Kwee, Thomas C.
    ACTA ONCOLOGICA, 2018, 57 (08) : 1128 - 1130
  • [49] Extracellular vesicle miRNA predict FDG-PET status in patients with classical Hodgkin Lymphoma
    Drees, Esther E. E.
    Roemer, Margaretha G. M.
    Groenewegen, Nils J.
    Perez-Boza, Jennifer
    van Eijndhoven, Monique A. J.
    Prins, Leah I.
    Verkuijlen, Sandra A. W. M.
    Tran, Xuan-Mai
    Driessen, Julia
    Zwezerijnen, G. J. C.
    Stathi, Phylicia
    Mol, Kevin
    Karregat, Joey J. J. P.
    Kalantidou, Aikaterini
    Valles-Marti, Andrea
    Molenaar, T. J.
    Aparicio-Puerta, Ernesto
    van Dijk, Erik
    Ylstra, Bauke
    Groothuis-Oudshoorn, Catharina G. M.
    Hackenberg, Michael
    de Jong, Daphne
    Zijlstra, Josee M.
    Pegtel, D. Michiel
    JOURNAL OF EXTRACELLULAR VESICLES, 2021, 10 (09)
  • [50] Interim FDG-PET in Hodgkin lymphoma: a compass for a safe navigation in clinical trials?
    Gallamini, Andrea
    Kostakoglu, Lale
    BLOOD, 2012, 120 (25) : 4913 - 4920